We have made significant strides in understanding aging through data, yet we have not effectively used this knowledge to prevent diseases like cancer and cardiovascular issues.

The big three age-related diseases—cancer, heart disease, and Alzheimer's—are exacerbated by age, and understanding the biology of aging could lead to breakthroughs in prevention.

American healthcare is in crisis, but we have a path to prevention that focuses on preventing age-related diseases rather than reversing aging.

Research on life extension is challenging due to the lack of clear endpoints in human studies, making it difficult to measure the impact of interventions on longevity.

Genetics is the second most important area; solving genetic diseases and preventing conditions like dementia or Alzheimer's would be wonderful.

Our internal drug design projects focus on immunology and oncology, and we've made significant progress using advanced models.

In my book, 'Super Agers', I discuss findings from a study where we found little genetic difference in people who reached 87 without age-related diseases, highlighting the importance of understanding the biology of aging.

We are now able to measure various biological factors, including the gut microbiome and epigenetics, which can help us understand aging better.

By around 2032, we will have made enough progress in scientific research to effectively stop aging, allowing people to live without the fear of dying from age-related causes.